ARPA-H Launches $100 Million EVIDENT Initiative to Pioneer Personalized Mental Health Treatments
ARPA-H under HHS launches $100M EVIDENT initiative for personalized mental health interventions,…
ARPA-H Launches $100 Million Initiative to Fast-Track Personalized Mental Health Treatments
ARPA-H commits $100M in federal funding to pioneer personalized mental health treatments,…
HHS ARPA-H Unveils $100 Million Push for Personalized Mental Health Treatments Using Cutting-Edge Tech
ARPA-H under HHS launches $100M for tech-driven personalized mental health treatments, targeting…
ARPA-H Pours $100 Million into Personalized Mental Health Breakthroughs via HHS Initiative
ARPA-H under HHS commits $100M to fast-track personalized mental health treatments, targeting…
FDA Approves Revolutionary Gene Therapy for Rare Neuromuscular Disease, Achieving 80% Efficacy in Halting Progression
FDA fast-tracks gene therapy for rare neuromuscular disorder XLMTM, with 80% efficacy…
CRISPR Breakthrough: UC Berkeley Gene Editing Trial Achieves 95% Symptom Reduction in Sickle Cell Patients
UC Berkeley's CRISPR trial for sickle cell disease achieves 95% symptom reduction,…
CRISPR Gene Editing Achieves First-Ever Cure for Rare Genetic Blood Disorder in Phase 3 Clinical Trial
In a historic first, CRISPR gene editing has cured beta-thalassemia in Phase…
CRISPR Breakthrough: Gene Editing Cures Rare Blindness in Pioneering Human Trial
In a medical first, CRISPR gene editing has cured a rare form…
CRISPR Breakthrough: First Human Cure for Rare Muscle-Wasting Genetic Disease Achieved in Boston Biotech Trial
Boston biotech Vertex announces complete remission of Duchenne muscular dystrophy in first…
